Sign in Pull a receipt

APVO

Aptevo Therapeutics Inc.

Healthcare · Biotechnology

$172.82 sample

+1.37 (+0.80%) 1D

Market cap

$100.5B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-02

Alerts

8

Price$172.82 +13.85% 3M daily closessample

174.41149.25

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider buy: Chief Financial Officer
Oct 12INSInsider buy: 10% owner
Oct 07INSInsider sell: 10% owner
Oct 02SEC8-K filed: material event
Sep 25SECDEF 14A filed
Sep 17INSInsider buy: Chief Executive Officer
Sep 11INSInsider sell: General Counsel
Sep 04SEC8-K filed: material event

Sign up to see the real APVO record →

Company facts

SEC EDGAR registration

Name: Aptevo Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -16sample, -100 to +100
Reporting currency: USD

Who is positioning in APVO

sample

Insiders: 25 insider transactions over 90 days, net selling, $889.9M
Congress: No member trades over 90 days
Institutions · 13F: 30 funds hold $2.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$5.3B +12.6% y/y

Q4 2024Q3 2026

Inventory$3.1B +7.5% y/y

Q4 2024Q3 2026

Accounts receivable$2.3B +5.9% y/y

Q4 2024Q3 2026

Total debt$6.3B +8.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $73.5B -11.0% 3M
Sample peer B: $81.4B +6.5% 3M
Sample peer C: $50.2B +3.3% 3M
Sample peer D: $96.1B +1.6% 3M
Sample peer E: $63.9B +2.3% 3M